Fate Therapeutics to Present at Upcoming Investor Conferences

GlobeNewswireFeb 14 16:01 ET

$FATE Stock Is up 21% Today. Here's What We See in Our Data.

Quiver QuantitativeFeb 14 10:31 ET

Leerink Partners Maintains Fate Therapeutics(FATE.US) With Buy Rating, Announces Target Price $12

Moomoo NewsFeb 14 01:32 ET · Ratings

Express News | Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

ReutersFeb 4 16:01 ET

We're Keeping An Eye On Fate Therapeutics' (NASDAQ:FATE) Cash Burn Rate

Yahoo FinanceFeb 4 08:25 ET

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Fate TherapeuticsFeb 4 00:00 ET